Literature DB >> 20825381

Immunologic characteristics of preeclampsia, a comprehensive review.

Hyunkyong Ahn1, Jooncheol Park, Alice Gilman-Sachs, Joanne Kwak-Kim.   

Abstract

Preeclampsia (PE) remains a leading cause of maternal and fetal morbidity and mortality. Despite decades of intense research on the problem, there is no early pregnancy screening test to recognize those at risk. Recently, altered immune responses have been suspected to be involved in preeclampsia pathogenesis, which may involve the inflammatory context in which an immune response is mounted. In this review, the immunologic pathogenesis of the PE is reviewed in context of innate and adaptive immunity (both cellular, i.e., T and NK cells, and humoral immunity) in relation to thrombophilic conditions.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20825381     DOI: 10.1111/j.1600-0897.2010.00913.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  30 in total

1.  The mucin MUC16 (CA125) binds to NK cells and monocytes from peripheral blood of women with healthy pregnancy and preeclampsia.

Authors:  Chanel Tyler; Arvinder Kapur; Mildred Felder; Jennifer A Belisle; Christine Trautman; Jennifer A A Gubbels; Joseph P Connor; Manish S Patankar
Journal:  Am J Reprod Immunol       Date:  2012-03-01       Impact factor: 3.886

Review 2.  Preeclampsia and health risks later in life: an immunological link.

Authors:  Shi-Bin Cheng; Surendra Sharma
Journal:  Semin Immunopathol       Date:  2016-06-23       Impact factor: 9.623

3.  Integration of metabolomic and transcriptomic networks in pregnant women reveals biological pathways and predictive signatures associated with preeclampsia.

Authors:  Rachel S Kelly; Damien C Croteau-Chonka; Amber Dahlin; Hooman Mirzakhani; Ann C Wu; Emily S Wan; Michael J McGeachie; Weiliang Qiu; Joanne E Sordillo; Amal Al-Garawi; Kathryn J Gray; Thomas F McElrath; Vincent J Carey; Clary B Clish; Augusto A Litonjua; Scott T Weiss; Jessica A Lasky-Su
Journal:  Metabolomics       Date:  2016-12-12       Impact factor: 4.290

4.  Senescent T cells and hypertension: new ideas about old cells.

Authors:  Meena S Madhur; David G Harrison
Journal:  Hypertension       Date:  2013-05-28       Impact factor: 10.190

5.  Lifetime Exposure to Intimate Partner Violence and Proinflammatory Cytokine Levels Across the Perinatal Period.

Authors:  Emma Robertson Blackmore; Mona Mittal; Xueya Cai; Jan A Moynihan; Monica M Matthieu; Thomas G O'Connor
Journal:  J Womens Health (Larchmt)       Date:  2016-01-08       Impact factor: 2.681

6.  Preeclampsia/Eclampsia candidate genes show altered methylation in maternal leukocytes of preeclamptic women at the time of delivery.

Authors:  Wendy M White; Zhifu Sun; Kristi S Borowski; Brian C Brost; Norman P Davies; Carl H Rose; Vesna D Garovic
Journal:  Hypertens Pregnancy       Date:  2016-04-11       Impact factor: 2.108

Review 7.  Perinatal depression--the fourth inflammatory morbidity of pregnancy?: Theory and literature review.

Authors:  Lauren M Osborne; Catherine Monk
Journal:  Psychoneuroendocrinology       Date:  2013-04-20       Impact factor: 4.905

8.  Ambient Fine Particulate Matter, Nitrogen Dioxide, and Hypertensive Disorders of Pregnancy in New York City.

Authors:  David A Savitz; Beth Elston; Jennifer F Bobb; Jane E Clougherty; Francesca Dominici; Kazuhiko Ito; Sarah Johnson; Tara McAlexander; Zev Ross; Jessie L C Shmool; Thomas D Matte; Gregory A Wellenius
Journal:  Epidemiology       Date:  2015-09       Impact factor: 4.822

9.  Evidence of sexual dimorphism in the placental function with severe preeclampsia.

Authors:  S Muralimanoharan; A Maloyan; L Myatt
Journal:  Placenta       Date:  2013-09-29       Impact factor: 3.481

10.  Polymorphisms in inflammatory genes are associated with term small for gestational age and preeclampsia.

Authors:  Quaker E Harmon; Stephanie M Engel; Michael C Wu; Thomas M Moran; Jingchun Luo; Alison M Stuebe; Christy L Avery; Andrew F Olshan
Journal:  Am J Reprod Immunol       Date:  2014-04-04       Impact factor: 3.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.